Clinical and technical aspects of genomic diagnostics for precision oncology

Journal of Clinical Oncology

Volumn 35, Issue 9, 2017, Pages 929-933

  Sheikine, Yuri ^a   Kuo, Frank C ^b   Lindeman, Neal I ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER DIAGNOSIS; COPY NUMBER VARIATION; GENE AMPLIFICATION; GENOMICS; NEXT GENERATION SEQUENCING; ONCOLOGY; PERSONALIZED MEDICINE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW; SEQUENCE ANALYSIS; GENETIC SCREENING; GENETICS; HIGH THROUGHPUT SEQUENCING; HUMAN; NEOPLASMS; PROCEDURES;

GENETIC TESTING; GENOMICS; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; NEOPLASMS; PRECISION MEDICINE;

EID: 85016399083     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2016.70.7539     Document Type: Review

References (20)

1. Zhen C, Wang YL: Molecular monitoring of chronic myeloid leukemia: International standardization of BCR-ABL1 quantitation. J Mol Diagn 15: 556-564, 2013
2. National Comprehensive Cancer Network: NCCN Guidelines. https://www.nccn.org/professionals/physician-gls/f-guidelines.asp
3. Stein EM: IDH2 inhibition in AML: Finally progress? Best Pract Res Clin Haematol 28:112-115, 2015
4. Wong DJ, Ribas A: Targeted therapy for melanoma. Cancer Treat Res 167:251-262, 2016
5. Roberts KG, Li Y, Payne-Turner D, et al: Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia. N Engl J Med 371: 1005-1015, 2014
6. Rizvi NA, Hellmann MD, Snyder A, et al: Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer. Science 348:124-128, 2015
7. Hirshfield KM, Tolkunov D, Zhong H, et al: Clinical actionability of comprehensive genomic profiling for management of rare or refractory cancers. Oncologist 21:1315-1325, 2016
8. Biesecker LG, Green RC: Diagnostic clinical genome and exome sequencing. N Engl J Med 371: 1170, 2014
9. Coonrod EM, Durtschi JD, Margraf RL, et al: Developing genome and exome sequencing for candidate gene identification in inherited disorders: An integrated technical and bioinformatics approach. Arch Pathol Lab Med 137:415-433, 2013
10. Catenacci DV, Amico AL, Nielsen SM, et al: Tumor genome analysis includes germline genome: Are we ready for surprises? Int J Cancer 136: 1559-1567, 2015
11. Kuo FC, Dong F: Next-generation sequencingbased panel testing for myeloid neoplasms. Curr Hematol Malig Rep 10:104-111, 2015
12. Ghoneim DH, Myers JR, Tuttle E, et al: Comparison of insertion/deletion calling algorithms on human next-generation sequencing data. BMC Res Notes 7:864, 2014
13. Nakao M, Yokota S, Iwai T, et al: Internal tandem duplication of the flt3 gene found in acute myeloid leukemia. Leukemia 10:1911-1918, 1996
14. Klampfl T, Gisslinger H, Harutyunyan AS, et al: Somatic mutations of calreticulin in myeloproliferative neoplasms. N Engl J Med 369:2379-2390, 2013
15. Heinrich MC, Corless CL, Demetri GD, et al: Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor. J Clin Oncol 21:4342-4349, 2003
16. Shen W, Szankasi P, Sederberg M, et al: Concurrent detection of targeted copy number variants and mutations using a myeloid malignancy next generation sequencing panel allows comprehensive genetic analysis using a single testing strategy. Br J Haematol 173:49-58, 2016
17. Suzuki T, Tsurusaki Y, Nakashima M, et al: Precise detection of chromosomal translocation or inversion breakpoints by whole-genome sequencing. J Hum Genet 59:649-654, 2014
18. Lindeman NI, Cagle PT, Beasley MB, et al: Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology. Arch Pathol Lab Med 137: 828-860, 2013
19. Gray PN, Dunlop CL, Elliott AM: Not all next generation sequencing diagnostics are created equal: understanding the nuances of solid tumor assay design for somatic mutation detection. Cancers (Basel) 7:1313-1332, 2015
20. Kulkarni S, Pfeifer JD (eds): Clinical Genomics. Academic Press, 2015